(Press-News.org) DALLAS -- Overactivity of a protein that normally cues cells to divide sabotages the body’s natural cellular recycling process, leading to heightened cancer growth and chemotherapy resistance, UT Southwestern Medical Center researchers have found.
The epidermal growth factor receptor, or EGFR, is found at abnormally high levels on the surface of many types of cancer cells. The study, led by Dr. Beth Levine and published Sept. 12 in Cell, revealed that EGFR turns off autophagy, a process by which cells recycle unneeded parts, by binding to a protein, Beclin 1, which normally turns on the process. The researchers found that the deactivation of autophagy by EGFR led to more rapid tumor growth and chemotherapy resistance in mice implanted with non-small lung carcinoma cells.
“The fact that this type of cell surface receptor can directly interact with Beclin 1 and shut off autophagy provides fundamental insight into how certain oncogenes may cause cancer,” said Dr. Levine, director of the Center for Autophagy Research and a Howard Hughes Medical Institute (HHMI) investigator at UT Southwestern. “Our findings suggest that inactivation of autophagy may be a critically important factor in the progression of lung cancer.”
Earlier work in the laboratory of Dr. Levine identified beclin 1 as the first mammalian gene shown to function in autophagy. Defects in this gene may contribute not only to cancer, but also to aging, neurodegenerative diseases, and infectious diseases.
While the link between EGFR cell signaling action and cancer growth was known, with several pharmaceutical inhibitors of EGFR already on the market to combat cancer, exactly how this process worked was a mystery. This latest research uncovers Beclin 1 as one important way in which EGFR may derail the body’s cancer-fighting autophagy machinery to increase tumor growth.
A second finding in the new study related to chemotherapy resistance. Several clinical trials are currently ongoing to test inhibitors of autophagy as a means of overcoming the resistance to chemotherapeutic drugs that many tumors develop. Unexpectedly, Dr. Levine’s study found just the opposite: that autophagy inhibition may actually worsen chemotherapy outcomes for patients with specific cancer mutations. The researchers showed that cancer cells with reduced autophagy grew faster and were more resistant to chemotherapy than cancer cells with normal autophagy. Dr. Levine noted that these findings may apply to many different types of cancers, especially those that rely on EGFR (or related signaling molecules) for their rapid growth.
About 10 percent of lung cancer patients have mutations in the EGFR oncogene, according to Dr. John Minna, one of the study authors and Director of the Nancy B. and Jack L. Hamon Center for Therapeutic Oncology Research and the W.A. “Tex” and Deborah Moncrief Jr. Center for Cancer Genetics at UT Southwestern. For those patients in particular, this finding could have significant impact in developing a personalized, targeted therapy.
“The EGFR protein is one of our most important targets for lung cancer therapy -- especially in patients whose tumors have certain EGFR gene mutations,” Dr. Minna said. “We have oral medications that achieve dramatic clinical benefit and increase survival in this subset of patients, but even these successfully treated patients eventually become resistant to the treatment.
“These new findings are important for two reasons: First, they provide insight into how to extend EGFR-targeted therapy to a much larger group of lung cancer patients, including those whose tumors do not have mutations. Second, they provide a totally new approach to overcoming resistance to EGFR-targeted therapy.”
INFORMATION:
Other UT Southwestern researchers involved in the study were lead author Dr. Yongjie Wei, assistant professor of internal medicine; Zhongju Zou, HHMI research specialist; Dr. Nils Becker, a former research assistant in internal medicine; Dr. Matthew Anderson, a former postdoctoral researcher in internal medicine; Dr. Rhea Sumpter, instructor of internal medicine; Dr. Guanghua Xiao, associate professor of clinical sciences; Dr. Lisa Kinch, bioinformatics scientist in biochemistry; Dr. Prasad Koduru, professor of pathology; Dr. Nick Grishin, professor of biophysics and biochemistry and an HHMI investigator; and Dr. Michael Peyton, a senior research scientist in the Hamon Center for Therapeutic Oncology Research. Researchers from Johns Hopkins University School of Medicine and Columbia University Medical Center also participated.
The research was supported by three grants from the National Institutes of Health, including a Lung Cancer SPORE (Specialized Program of Research Excellence) grant from the National Cancer Institute.
About UT Southwestern Medical Center
UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution’s faculty has many distinguished members, including five who have been awarded Nobel Prizes since 1985. Numbering more than 2,700, the faculty is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide medical care in 40 specialties to nearly 90,000 hospitalized patients and oversee more than 1.9 million outpatient visits a year.
This news release is available on our home page at utsouthwestern.edu/home/news/index.html
To automatically receive news releases from UT Southwestern via email, subscribe at UT Southwestern.edu/receivenews
Interference with cellular recycling leads to cancer growth, chemotherapy resistance
2013-09-18
ELSE PRESS RELEASES FROM THIS DATE:
Studies: Motor control development continues longer than previously believed
2013-09-18
The development of fine motor control—the ability to use your fingertips to manipulate objects—takes longer than previously believed, and isn't entirely the result of brain development, according to a pair of complementary studies.
The research opens up the potential to use therapy to continue improving the motor control skills of children suffering from neurodevelopmental disorders such as cerebral palsy, a blanket term for central motor disorders that affects about 764,000 children and adults nationwide
"These findings show that it's not only possible but critical ...
Today's worst watershed stresses may become the new normal, study finds
2013-09-18
Nearly one in 10 U.S. watersheds is "stressed," with demand for water exceeding natural supply, according to a new analysis of surface water in the United States. What's more, the lowest water flow seasons of recent years -- times of great stress on rivers, streams, and sectors that use their waters -- are likely to become typical as climates continue to warm.
"By midcentury, we expect to see less reliable surface water supplies in several regions of the United States," said the study's lead author, Kristen Averyt, associate director for science at the Cooperative Institute ...
NASA sees Tropical Storm Usagi's central and southern power
2013-09-18
Powerful thunderstorms wrapped around Tropical Storm Usagi's center and its southern quadrant in visible data from NASA's Aqua satellite on Sept. 18.
When NASA's Aqua satellite passed over Usagi on Sept. 18 at 04:40 UTC/12:40 a.m. EDT, the Moderate Resolution Imaging Spectroradiometer known better as "MODIS" took a picture of the northwestern Pacific Ocean storm. The image showed thick bands of powerful thunderstorms south of the center of circulation, and wrapping tightly around the center. Convective banding was also developing in other quadrants of the storm, indicating ...
Smartphone app found to be valid tool in screening for minimal hepatic encephalopathy
2013-09-18
A smartphone app can quickly screen for cognitive dysfunction often found in patients with cirrhosis, according to a new Virginia Commonwealth University study. The cognitive dysfunction, known as minimal hepatic encephalopathy (MHE), has been difficult to diagnose.
Published in the September issue of the journal Hepatology, the study tested the validity of the Stroop smartphone application – called EncephalApp_Stroop – as a method to screen for MHE.
Validation of the app as a health care tool opens the door for its use as a point-of-care (POC) instrument that providers ...
NASA's TRMM satellite and HS3 mission checking out Tropical Storm Humberto
2013-09-18
NASA's TRMM satellite watched Tropical Storm Humberto's rainfall pick up over two days as it re-formed, and as part of NASA's HS3 mission, two of NASA's Global Hawk unmanned aircraft have been investigating the zombie storm. The two Global Hawks also celebrated a combined 100 flights.
NASA's Global Hawk 871 departed from NASA's Wallops Flight Facility, Wallops Island, Va. today, Sept. 17, at 10 a.m. EDT from Runway 04. This marked the twenty-fifth flight for NASA 871. Meanwhile, NASA 872 was returning to home base after making its seventy-fifth flight. These flights ...
NASA's TRMM satellite animation gives flyby of Tropical Storm Ingrid's heavy rains
2013-09-18
VIDEO:
This 3-D flyby of Tropical Storm Ingrid's rainfall was created from TRMM satellite data for Sept. 16. Heaviest rainfall appears in red towers over the Gulf of Mexico, while moderate...
Click here for more information.
NASA's Tropical Rainfall Measuring Mission satellite known as TRMM can compile the rain in which rain is falling as it orbits from space. When it passed over Tropical Storm Ingrid on Sept. 16 TRMM gathered data and it was used to create a NASA 3-D flyby ...
NASA's TRMM satellite adds up Tropical Storm Manuel's amazing rainfall
2013-09-18
Tropical Storm Manuel dropped very heavy rains that caused floods and mudslides and took lives on Mexico's Pacific coast. Manuel's rainfall was captured and tallied from NASA's Tropical Rainfall Measuring Mission satellite known as TRMM.
Tropical storm Manuel may have dissipated, but the storm dropped very heavy rainfall along Mexico's Pacific coast where 21 people have been reported killed due to flooding and landslides caused by extreme rainfall. At the same time, on Sept. 16, Hurricane Ingrid weakened to a tropical storm and came ashore from the Gulf of Mexico into ...
Driving cessation hinders aging adults' volunteer and work lives, social lives okay in short term
2013-09-18
COLUMBIA, Mo. – For many senior drivers, it is only a matter of time before they are forced to give up their car keys due to failing eyesight or other health issues. Now, University of Missouri researchers have studied how aging adults' driving cessation influences their work and social lives. The researchers found that seniors' loss of driving independence negatively affected their ability to work and their volunteerism; the adults' social lives were not instantly affected yet dwindled over time.
"We found that seniors' productive engagement, such as paid work and formal ...
Proton weak charge determined for first time
2013-09-18
NEWPORT NEWS, VA, Sept. 17, 2013 – Researchers have made the first experimental determination of the weak charge of the proton in research carried out at the Department of Energy's Thomas Jefferson National Accelerator Facility (Jefferson Lab).
The results, accepted for publication in Physical Review Letters, also include the determinations of the weak charge of the neutron, and of the up quark and down quark. These determinations were made by combining the new data with published data from other experiments. Although these preliminary figures are the most precise determinations ...
New muscular dystrophy treatment shows promise in early study led by Children's National
2013-09-18
WASHINGTON, DC — A preclinical study led by researchers at Children's National Medical Center has found that a new oral drug shows early promise for the treatment of Duchenne muscular dystrophy (DMD). The results, published in EMBO Molecular Medicine, show that the drug, VBP15, decreases inflammation and protects and strengthens muscle without the harsh side effects linked to current treatments with glucocorticoids such as prednisone.
Duchenne muscular dystrophy results in severe muscle degeneration and affects approximately 180,000 patients worldwide, mostly children. ...